<html>
<head>PUBMED IDs for OCIAD2</head>
<body bgcolor='#C5F0F2'><h1>OCIAD2</h1><a href='https://pubmed.ncbi.nlm.nih.gov/17054434/'>OCIA domain containing 2 is highly expressed in adenocarcinoma mixed subtype with bronchioloalveolar carcinoma component and is associated with better prognosis.</a> October 24  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17054428/'>Haemoglobin H hydrops fetalis syndrome associated with homozygosity for the alpha2-globin gene polyadenylation signal mutation AATAAA--&gt;AATA- -.</a> October 24  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/24270855/'>OCIAD2 activates γ-secretase to enhance amyloid β production by interacting with nicastrin.</a> August 19  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24949437/'>Pathway bridge based multiobjective optimization approach for lurking pathway prediction.</a> February 14  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/26991471/'>Clinical prognostic value of DNA methylation in hepatoblastoma: Four novel tumor suppressor candidates.</a> February 1  2016<br></body></html>
